e-learning
resources
Stockholm 2007
Monday 17.09.2007
Recent advances in our understanding of the mechanisms of asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of ligustrazine inhalation on the expression of stem cells factor (SCF) in mouse asthma models
K. Yin, J. Liu, X. Zhang (Nanjing, China)
Source:
Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment
Session:
Recent advances in our understanding of the mechanisms of asthma treatment
Session type:
Thematic Poster Session
Number:
2170
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Yin, J. Liu, X. Zhang (Nanjing, China). Effect of ligustrazine inhalation on the expression of stem cells factor (SCF) in mouse asthma models. Eur Respir J 2007; 30: Suppl. 51, 2170
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Pretreatment of human adipose derived mesenchymal stem cells with PPAR-γ agonist improved effects of regeneration in elastase induced emphysema mouse model
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
Effect of low level laser (LLL) and mesenchymal stem cells (htMSCs) therapies on cigarette-induced lung inflammation in mice
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Mesenchymal stem cell based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysacharride in mice
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008
The anti-asthmatic mechanisms and effect of interfering expression of IL 5 Rα on the differentiation of bone marrow CD34
+
progenitors of asthma mice
Source: Eur Respir J 2006; 28: Suppl. 50, 225s
Year: 2006
Therapeutic effects of human perivascular stem cells in an emphysema mouse model
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017
Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma
Source: Eur Respir J 2011; 38: 679-687
Year: 2011
Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Protective effect of thrombomodulin-positive dendritic cells against murine asthma
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Effect of dexamethasone on TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells - role of histone-acetylation
Source: Eur Respir J 2004; 24: Suppl. 48, 695s
Year: 2004
Effects of treatment with angiotensin-(1-7) on antigen sensitization of murine experimental model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012
PP213 – Adoptive transfer of hepatocyte growth factor transfected T cells in a bleomycin injured murine lung model
Source: ERS Lung Science Conference 2021
Year: 2021
Overexpression of B cell activating factor (BAFF) in peripheral lung of COPD patients
Source: Annual Congress 2009 - Pathology and immunology of COPD
Year: 2009
Differing effects of montelukast and ketotifen on cytokine expression in human myeloid dendritic cells
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Therapeutic potential of mesenchymal stem cells modified to secrete anti-inflammatory protein sST2 in a model of occupational asthma
Source: Annual Congress 2012 - Occupational asthma
Year: 2012
Exogenous administration of bone marrow-derived stem cells in experimental COPD
Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Year: 2013
Electroporation-mediated HGF gene transfer increases mesenchymal stem cell and decreases MMP24 levels in a bleomycin-induced lung injury model.
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Inhibitory activity of fluticasone propionate (FP), on the constitutive or cytokine-induced bronchial epithelial cell (HBECs) functions
in vitro
Source: Eur Respir J 2003; 22: Suppl. 45, 76s
Year: 2003
Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept